Takashi Tsukamoto

18PUBLICATIONS
50CO-AUTHORS
GlycoconjugatesBiomolecular modelling and designGene and molecular therapyProteins and peptidesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 29, 2026
Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metabolite.

|Feb 12, 2026
Discovery of N-Acetyltransferase 8-Like (NAT8L) inhibitors based on a N-Acylated (Piperidin-3-ylmethyl)-1,2,4-Oxadiazole Scaffold.

Md Junayed Nayeen, Ajit G Thomas, Biswajit Kundu

|Dec 17, 2025
An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain-related behaviors in humanized mice.

Ankit Uniyal, Niyada Hin, Chi Zhang

|Aug 29, 2025
Prodrugs 2-(Phosphonomethyl)pentanedioic Acid (2-PMPA) as Orally Available Glutamate Carboxypeptidase II Inhibitors.

Niyada Hin, Chae Bin Lee, Sadakatali Gori

|Aug 13, 2025
D-cysteine impairs tumour growth by inhibiting cysteine desulfurase NFS1.

Joséphine Zangari, Oliver Stehling, Sven A Freibert

|Aug 06, 2024
A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation.

Chiaki T Ishida, Casie S Kubota, Evan Carlyle

Pageof 3

Frequent Collaborators

13 joint publications

Barbara S Slusher

8 joint publications

Rana Rais

2 joint publications

Huijun Wei

2 joint publications

Junlin Zhuo